Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiocca

Showing results (631-640 of 728) with videos related to

Pageof 73
Sort By:
BMC Infectious Diseases|February 16, 2023
Correction: European Cohorts of patients and schools to Advance Response to Epidemics (EuCARE): a cluster randomised interventional and observational study protocol to investigate the relationship between schools and SARS-CoV-2 infectionSara Raimondi, Sara Gandini, Gibran Horemheb Rubio Quintanares, et al.
BMC Infectious Diseases|January 3, 2023
European Cohorts of patients and schools to Advance Response to Epidemics (EuCARE): a cluster randomised interventional and observational study protocol to investigate the relationship between schools and SARS-CoV-2 infectionSara Raimondi, Sara Gandini, Gibran Horemheb Rubio Quintanares, et al.
Oncoimmunology|February 6, 2018
Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cellsTiphaine Delaunay, Mathilde Violland, Nicolas Boisgerault, et al.
Pharmacology & Therapeutics|October 10, 2025
Treatment strategies for leptomeningeal disease in patients with breast cancerLennard Spanehl, Thomas Grinda, Rishab Ramapriyan, et al.
Cell|February 12, 2026
Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trialMaxime Meylan, Ye Tian, Lijian Wu, et al.
Scientific Reports|May 4, 2021
Author Correction: A role for the immune system in advanced laryngeal cancerMarta Tagliabue, Fausto Maffini, Caterina Fumagalli, et al.
Frontiers in Oncology|August 21, 2024
Is precision medicine the solution to improve organ preservation in laryngeal/hypopharyngeal cancer? A position paper by the Preserve Research GroupDavide Mattavelli, Gunnar Wichmann, Davide Smussi, et al.
World Neurosurgery|July 15, 2022
Carole A. Miller, MD: Matriarch of the Ohio State University's Department of NeurosurgeryDaniel S Ikeda, E Antonio Chiocca, Russel R Lonser, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 17, 2012
Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virusHiroaki Uchida, Marco Marzulli, Kenji Nakano, et al.
Scientific Reports|July 10, 2015
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem CellsJianfeng Han, Jianhong Chu, Wing Keung Chan, et al.
Pageof 73

Showing results (631-640 of 728) with videos related to

Sort By:
Pageof 73
BMC Infectious Diseases|February 16, 2023
Correction: European Cohorts of patients and schools to Advance Response to Epidemics (EuCARE): a cluster randomised interventional and observational study protocol to investigate the relationship between schools and SARS-CoV-2 infectionSara Raimondi, Sara Gandini, Gibran Horemheb Rubio Quintanares, et al.
BMC Infectious Diseases|January 3, 2023
European Cohorts of patients and schools to Advance Response to Epidemics (EuCARE): a cluster randomised interventional and observational study protocol to investigate the relationship between schools and SARS-CoV-2 infectionSara Raimondi, Sara Gandini, Gibran Horemheb Rubio Quintanares, et al.
Oncoimmunology|February 6, 2018
Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cellsTiphaine Delaunay, Mathilde Violland, Nicolas Boisgerault, et al.
Pharmacology & Therapeutics|October 10, 2025
Treatment strategies for leptomeningeal disease in patients with breast cancerLennard Spanehl, Thomas Grinda, Rishab Ramapriyan, et al.
Cell|February 12, 2026
Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trialMaxime Meylan, Ye Tian, Lijian Wu, et al.
Scientific Reports|May 4, 2021
Author Correction: A role for the immune system in advanced laryngeal cancerMarta Tagliabue, Fausto Maffini, Caterina Fumagalli, et al.
Frontiers in Oncology|August 21, 2024
Is precision medicine the solution to improve organ preservation in laryngeal/hypopharyngeal cancer? A position paper by the Preserve Research GroupDavide Mattavelli, Gunnar Wichmann, Davide Smussi, et al.
World Neurosurgery|July 15, 2022
Carole A. Miller, MD: Matriarch of the Ohio State University's Department of NeurosurgeryDaniel S Ikeda, E Antonio Chiocca, Russel R Lonser, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 17, 2012
Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virusHiroaki Uchida, Marco Marzulli, Kenji Nakano, et al.
Scientific Reports|July 10, 2015
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem CellsJianfeng Han, Jianhong Chu, Wing Keung Chan, et al.
Pageof 73